These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17083565)

  • 21. Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma.
    Tölle A; Suhail S; Jung M; Jung K; Stephan C
    BMC Cancer; 2011 Jul; 11():302. PubMed ID: 21767383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
    Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
    Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
    Kim SH; Park WS; Park EY; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
    PLoS One; 2017; 12(6):e0179610. PubMed ID: 28654655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival.
    Zhang X; Ren J; Yan L; Tang Y; Zhang W; Li D; Zang Y; Kong F; Xu Z
    PLoS One; 2015; 10(3):e0118659. PubMed ID: 25751257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of S100 protein in renal cell carcinoma and its relation with P53].
    Yang JF; Zhang XY; Qi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):301-4. PubMed ID: 16136965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.
    Giribaldi G; Barbero G; Mandili G; Daniele L; Khadjavi A; Notarpietro A; Ulliers D; Prato M; Minero VG; Battaglia A; Allasia M; Bosio A; Sapino A; Gontero P; Frea B; Fontana D; Destefanis P
    J Proteomics; 2013 Oct; 91():385-92. PubMed ID: 23916412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of DLC-1 in clear cell renal cell carcinoma: prognostic significance for progression and metastasis.
    Zhang T; Zheng J; Liu C; Lu Y
    Urol Int; 2009; 82(4):380-7. PubMed ID: 19506402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association of S100A4 mRNA expression with differentiation and metastasis of renal cell carcinoma].
    Zhou HK; Zhao YB; Zheng SB; Chen T; Mao XM; Qi H; Wu RJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):712-4, 717. PubMed ID: 15958317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.
    Bismar TA; Bianco FJ; Zhang H; Li X; Sarkar FH; Sakr WA; Grignon DJ; Che M
    Pathology; 2003 Dec; 35(6):513-7. PubMed ID: 14660102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
    Visapää H; Bui M; Huang Y; Seligson D; Tsai H; Pantuck A; Figlin R; Rao JY; Belldegrun A; Horvath S; Palotie A
    Urology; 2003 Apr; 61(4):845-50. PubMed ID: 12670587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma.
    Gervais ML; Henry PC; Saravanan A; Burry TN; Gallie BL; Jewett MA; Hill RP; Evans AJ; Ohh M
    Lab Invest; 2007 Dec; 87(12):1252-64. PubMed ID: 17906660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
    Kempkensteffen C; Hinz S; Christoph F; Krause H; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
    J Cancer Res Clin Oncol; 2008 May; 134(5):543-50. PubMed ID: 17922292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of periostin splice variants in renal cell carcinoma.
    Morra L; Rechsteiner M; Casagrande S; Duc Luu V; Santimaria R; Diener PA; Sulser T; Kristiansen G; Schraml P; Moch H; Soltermann A
    Am J Pathol; 2011 Sep; 179(3):1513-21. PubMed ID: 21763681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters.
    Tsai WC; Sheu LF; Nieh S; Yu CP; Sun GH; Lin YF; Chen A; Jin JS
    World J Urol; 2007 Mar; 25(1):73-80. PubMed ID: 17021824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
    Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
    Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis.
    Zhang S; Fang J; Zhang X; Qin C; Su S; Deng Y; Song Z; Zhang Y; Wang H; Yin C; Wang Z
    Tumour Biol; 2014 Sep; 35(9):9095-100. PubMed ID: 25027395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.